Anatomy
Mohammad Mahdi Vashghani Farahani; Reza Farahani; Mohammad-Amin Abdollahifar; Mahdi Ghatrehsamani; Seyed Kamran Ghoreishi; Behnam Hajihossainlou; Sufan Chien; Atarodsadat Mostafavinia; Fatemehalsadat Rezaei; Mohammad Bayat
Volume 10, Issue 2 , June 2019, , Pages 93-100
Abstract
Osteoporosis is determined by decreased bone strength that increases the threat of fractures. The aim of this study was to evaluate the effects of pentoxifylline (PTX) and alendronate (ALN), on the stereological parameters, and gene expression in callus of fracture in an experimental rat model of ovariectomy-induced ...
Read More
Osteoporosis is determined by decreased bone strength that increases the threat of fractures. The aim of this study was to evaluate the effects of pentoxifylline (PTX) and alendronate (ALN), on the stereological parameters, and gene expression in callus of fracture in an experimental rat model of ovariectomy-induced osteoporosis (OVX). The OVX was induced in 90 female rats. Fourteen weeks later, a complete fracture on the right femur was made. Rats were divided into five groups: 1) control: no treatment; 2) sham: received daily distilled water; 3) daily 3.00 mg kg-1 ALN subcutaneously (SC); 4) daily 200 mg kg-1 PTX (SC) and 5) daily PTX (SC) + ALN (same doses). The osteoclast count was significantly lower in all treatment groups, at 21 and 56 days post-surgery, compared to the control and sham groups. The PTX significantly increased total callus volume at 21 and 56 days post-surgery, compared to the other groups. The PTX+ALN treatment significantly increased both cortical bone volume on day 21, and osteocyte and osteoblast numbers on day 56, compared to the control and sham groups. It can be concluded that PTX and ALN have antiresorptive effects, in OVX rats. Also, PTX has increased the extracellular matrix on both 21 and 56 days after surgery, compared to the other groups. PTX+ALN elevated cortical bone volume on day 21, and osteocyte and osteoblast numbers compared to the control and sham groups on day 56.
Morteza Saravani; Hossein Kazemi Mehrjerdi; Ali Mirshahi; Amir Afkhami Goli
Volume 5, Issue 4 , December 2014, , Pages 263-267
Abstract
The pomegranate seed oil (PSO), containing 17-α-estradiol, is one of the newly found phytosterols with synergistic health effects on estrogen related physiological conditions. Herein, PSO was assessed for its potential improving effects on bone characteristics in a rat model of menopausal syndrome. ...
Read More
The pomegranate seed oil (PSO), containing 17-α-estradiol, is one of the newly found phytosterols with synergistic health effects on estrogen related physiological conditions. Herein, PSO was assessed for its potential improving effects on bone characteristics in a rat model of menopausal syndrome. Three month old non-pregnant female Wistar rats (n = 30) were either sham-operated (SHAM) or ovariectomized (OVX), each divided into two further groups receiving 0.1 mL PSO or the same volume of paraffin oil as placebo. Before the operation and 67 days after it, multi-detector computed tomography (MDCT) scanning was performed with the identical setup option for the scanner to measure the bone mineral density (BMD) in body of 12th thoracic vertebra, 1st to 6th lumbar vertebra and sacrum. This study revealed that bone density of 1st, 3rd, 5th, 6th and sacrum body were significantly different between OVX and SHAM groups during the study period. In conclusion, PSO during 67 days study could not completely prevent the osteoporotic effects caused by ovariectomy in vertebral column of rats.